Elevated plasma natriuretic peptide levels were associated with cardiovascular events

Newby, L. Kristin
September 2004
ACP Journal Club;Sep/Oct2004, Vol. 141 Issue 2, p50
Academic Journal
This article discusses the relationship of plasma natriuretic peptide levels and the risk of cardiovascular events and death. In asymptomatic persons without preexisting heart failure, both elevated brain and proatrial natriuretic peptide levels were associated with increased incidence of cardiovascular events, particularly heart failure, atrial fibrillation, and death. According to researchers a graded relation exists between levels of natriuretic peptide levels within the normal range and the risk for cardiovascular events over an average of 5.2 years in unselected, asymptomatic patients.


Related Articles

  • Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF. Cleland, John G.F.; Coletta, Alison P.; Abdellah, Ahmed Tageldien; Witte, Klaus K.; Hobson, Neil; Clark, Andrew L. // European Journal of Heart Failure;Aug2007, Vol. 9 Issue 8, p850 

    Abstract: This article provides information and a commentary on trials relevant to the pathophysiology, prevention and treatment of heart failure, presented at Heart Rhythm 2007 organised by the Heart Rhythm Society which was held in Denver, USA and Heart Failure 2007 organised by the Heart...

  • Warfarin prevents more strokes than clopidogrel and aspirin in afib.  // Journal of Family Practice;Sep2006, Vol. 55 Issue 9, p753 

    The article offers information on the effect of warfarin in the reduction of strokes. A comparison was made between the healing effect of warfarin and clopidogrel plus aspirin in preventing strokes in patients with atrial fibrilation. Moreover, it is identified that warfarin is superior to the...

  • The role of natriuretic peptides in cardioprotection. Nishikimi, Toshio; Maeda, Nobuyo; Matsuoka, Hiroaki // Cardiovascular Research;Feb2006, Vol. 69 Issue 2, p318 

    Abstract: Atrial natriuretic peptide (ANP) and brain (B-type) natriuretic peptide (BNP) are circulating hormones of cardiac origin that play an important role in the regulation of intravascular blood volume and vascular tone. The plasma concentrations of ANP and BNP are elevated in heart...

  • ATRIAL FIBRILLATION.  // Mayo Clinic Women's Health Source;Nov2009, Vol. 13 Issue 11, p1 

    The article discusses atrial fibrillation, a heart rhythm problem wherein the electrical signals in the atria are chaotic, causing the ventricle to quiver. As a result, the atria becomes less effective at pumping blood to the ventricles, causing blood to pool in the upper chambers and form...

  • Revised ACC/AHA heart failure guidelines released.  // Pharmacy Today;Jun2009, Vol. 15 Issue 6, p1 

    The article reports on the release of the new heart failure guidelines revised by the American College of Cardiology (ACA) and American Heart Association (AHA). The new manual will provide support concerning the use of combined hydrazaline and isosorbide dinitrate therapy in order to improve...

  • Journal Scan. Gorog, Diana; Kapur, Akhil; Khan, Masood; Lindsay, Alistair; Sharp, Andrew // Heart;Feb2005, Vol. 91 Issue 2, p271 

    The article presents abstracts of several abstracts related to heart diseases. In the past decade, the radial artery has frequently been used for coronary bypass surgery, despite concern regarding the possibility of graft spasm. Congestive heart failure and atrial fibrillation (AF) often...

  • Antiadrenergic Therapy in the Control of Atrial Fibrillation. Naccarelli, Gerald V. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2005 Supplement, Vol. 10 Issue 2S, pS33 

    The article reports that atrial fibrillation (AF) in heart failure develops commonly in older individuals and its prevalence increases as heart failure severity progresses. The onset of intermittent or sustained AF in patients with established heart failure may exacerbate heart failure symptoms,...

  • Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation. Okura, H.; Takada, Y.; Kubo, I.; Iwata, K.; Mizoguchi, S.; Taguchi, H.; Toda, I.; Yoshikawa, J.; Yoshida, K. // Heart;Sep2006, Vol. 92 Issue 9, p1248 

    Objectives: To investigate whether the ratio of early transmitral flow velocity (E) to early diastolic mitral annular velocity (E') predict prognosis in patients with non-valvular atrial fibrillation. Methods: 230 patients with non-valvular atrial fibrillation were enrolled and studied....

  • Biomarkers and heart disease: Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men. Kurl, S.; Ala-Kopsala, M.; Ruskoaho, H.; Mäkikallio, T.; Nyyssönen, K.; Vuolteenaho, O.; Sivenius, J.; Salonen, J. T.; Laukkanen, J. A. // Heart;Jul2009, Vol. 95 Issue 13, p20 

    Background: Risk stratification for cardiovascular outcomes is gaining importance in general population. Prognostic value of natriuretic peptides has been established in patients with heart failure. However, the prognostic significance of natriuretic peptides with respect to stroke is not well...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics